Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 5, 2015, after the close
10-Q filed Nov 5, 2015, 36 days after period end · 0001193125-15-368368
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $39.00K | $15.00K | $240.00K | $3.48M |
| Net Income | -$38.91M | -$24.79M | -$10.70M | -$2.40M |
| EPS Diluted | -$0.39 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.25 |
| -$0.12 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
